Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Cancer Immunology, Immunotherapy : CII|May 16, 2007
Current approaches in dendritic cell generation and future implications for cancer immunotherapySandra Tuyaerts, Joeri L Aerts, Jurgen Corthals, et al.
Archives of Gerontology and Geriatrics|August 17, 2015
Aging-associated subpopulations of human CD8+ T-lymphocytes identified by their CD28 and CD57 phenotypesOscar Okwudiri Onyema, Rose Njemini, Louis Nuvagah Forti, et al.
European Journal of Immunology|February 16, 2007
CD83 expression on dendritic cells and T cells: correlation with effective immune responsesCindy Aerts-Toegaert, Carlo Heirman, Sandra Tuyaerts, et al.
Cancer Immunology, Immunotherapy : CII|June 21, 2014
Immunomodulatory drugs improve the immune environment for dendritic cell-based immunotherapy in multiple myeloma patients after autologous stem cell transplantationBrenda De Keersmaecker, Karel Fostier, Jurgen Corthals, et al.
NPJ Vaccines|March 2, 2023
Autologous dendritic cell vaccination against HIV-1 induces changes in natural killer cell phenotype and functionalityThessa Laeremans, Sabine den Roover, Cynthia Lungu, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
The interferon inducer ampligen [poly(I)-poly(C12U)] markedly protects mice against coxsackie B3 virus-induced myocarditisElizaveta Padalko, Dieter Nuyens, Armando De Palma, et al.
Cancer Research|September 20, 2006
Quantifying the activity of adenoviral E1A CR2 deletion mutants using renilla luciferase bioluminescence and 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography imagingJulius Leyton, Michelle Lockley, Joeri L Aerts, et al.
Cancer Immunology, Immunotherapy : CII|April 22, 2016
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustionStephanie Du Four, Sarah K Maenhout, Daphné Benteyn, et al.
International Journal of Cancer|February 22, 2018
Immune checkpoint blockade combined with IL-6 and TGF-β inhibition improves the therapeutic outcome of mRNA-based immunotherapyLukasz Bialkowski, Kevin Van der Jeught, Sanne Bevers, et al.
Journal of Leukocyte Biology|April 24, 2007
Expression of human GITRL on myeloid dendritic cells enhances their immunostimulatory function but does not abrogate the suppressive effect of CD4+CD25+ regulatory T cellsSandra Tuyaerts, Sonja Van Meirvenne, Aude Bonehill, et al.
Pageof 6